HS/KN kods 30021098 EUDR sagatavošanas nolūkā: neietilpst darbības jomā.
Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins) Indeksētais darbības jomas dzinējs šim kodam atgriež Out of scope. No Annex I scope match was found for this indexed CN code.
Kāpēc šī uzziņas lapa sniedz tādu atbildi.
- Koda apraksts
- Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
- I pielikuma pamats
- Nav tieša I pielikuma ieraksta
- Avota pamats
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Augstāka līmeņa, pakārtotās un tuvās rindas.
Bibliotēkas skats paredzēts uzziņu navigācijai. Izmantojiet pārbaudītāju, ja vēlaties pārbaudīt citu kodu kā darbību.
30pharmaceutical productsout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021010antisera(2012-2016);antisera(2002-2011);antisera(1988-2001)out30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Ko tas nozīmē sagatavošanai.
Pašreizējā darbības jomas rezultātā šī rinda tieši nerosina pierādījumu vākšanu.
Regulation (EU) 2023/1115 Annex I — relevant productsiegūts 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115iegūts 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)iegūts 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)iegūts 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8iegūts 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingiegūts 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersiegūts 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)iegūts 2026-08-08